The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

Questions: Discounts, Updates etc.

Pages: 260

Price (Single): $3,000.00

Price (Company): $6,000.00

Publication Date: 2006-03-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

This report on the U.S. market for over-the-counter (OTC) pediatric medications presents an in-depth analysis of the performance of non-prescription pediatric drugs and other selected pediatric healthcare products in the marketplace. The analysis captures the performance of the market players, categories, and leading brands in terms of revenue growth and volume growth in several categories of medication, including

In addition to detailed sales and market share figures by brand and marketer, the report also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace, details the demographics of the various brand users, provides insight in usage pattern of the pediatric OTC products, and profiles 12 leading marketers.

Table of Contents

CHAPTER I: EXECUTIVE SUMMARY

CHAPTER II: THE MARKET

CHAPTER III: THE MARKETERS

CHAPTER IV: THE CONSUMER

  • OTC Children’s Cough-Cold Products
    • Consumer Usage by Type
    • Children's Tylenol Cold - the Most Preferred Brand
    • Brand Preference by Demographics
  • Children’s Fever/Pain Relievers
    • Liquid Versus Chewable
    • Brand Loyalty for Children’s Fever/Pain Relief Products Across Demographics
    • Children's Tylenol - Highest Usage
    • Brand Preference by Demographics
    • Frequency of Usage
  • First Aid Bandage/Antibiotic
    • First Aid Ointment/Antiseptic Brands
    • Brand Preference by Demographics
      • Middle Age Group - Significant Users of Store Brands Antibiotics
      • Lower Income Group - Higher Preference for Store Brand Bandages
      • Brands for Anti-Itch
    • Adhesive Bandages
  • Simmons Kids Survey For Adhesive Bandages
    • Band-Aid - the Leading Brand Among Kids
    • Frequency of Usage

    CHAPTER V: MARKETING DYNAMICS

    • Advertising and Promotion
      • Johnson & Johnson Dominates Ad Spend
      • Tylenol Scholarship 2005
      • Price Discounts
      • The Cartoon Character Licensing Rage
    • Drug Distribution & Retailing Overview
      • Drug Store Chains
      • e-Pharmacies
    • Retail Trends
      • The Triaminic Clinic
      • Store Clinics
      • Drug Chains Aid Consumers
      • Drug Stores Outpace Overall Market
    • New Product Introductions
      • Quick Relief Products Sought the Most
      • Natural Products take Center Stage
      • Allergy-Free Products
      • Flavor Trends
    • InnovationCHAPTER VI: COMPANY PROFILES
      • Procter and Gamble
        • Overview
        • OTC Pediatric Medication Product Line
        • Improved Distribution Strategy
      • Johnson & Johnson
        • Overview
        • OTC Pediatric Medication Product Line
        • Innovation: The Key Growth Driver
        • Mint-flavored Cough-Cold Liquids
        • Mobile Marketing Tour
        • Children's Motrin Grape Chewables Alert
        • New Children's Tylenol Dye-Free
        • New Children’s Motrin
        • Jr. Tylenol Meltaways Stage 4 Fever Tablets
      • Novartis AG
        • Overview.
        • Innovation: Backbone of the company’s growth
      • Pfizer Inc
        • Overview
        • OTC Pediatric Medication Product Line
        • Pfizer’s Growth and Development Strategy
        • Pfizer’s Approval for New Chewable Formulation Of Zyrtec
        • New Products
          • PediaCare Gentle Vapors
          • Children's Pedia Care Medicated Freezer Pops
          • Children's Benadryl-D Allergy and Sinus Liquid
          • Infants' PediaCare Cough Suppressant Oral Drops
      • Wyeth
        • Overview
        • OTC Pediatric Medication Product Line
        • Expansion: The Driving Factor
        • FDA approves Children’s Advil Allergy Sinus for Over the Counter Use
      • Prestige Brands Holding, Inc
        • Overview
        • OTC Pediatric Medication Product Line
        • Future Growth Opportunity
      • Rohto Pharmaceutical Company Ltd
        • Overview
        • OTC Pediatric Medication Product Line
      • 3M Company
        • Overview
        • Nexcare: Unique Marketing Strategy
      • Beiersdorf AG
        • Overview
        • Curad
        • OTC Pediatric Medication Product Line
        • Beiersdorf's Plasters top the global market
        • New Product Introductions
        • Curad Shrek Sterile Assorted Bandages
        • Curad Silver Bandage
        • Curad Scar Therapy Clear Pads.
      • Bristol-Myers Squibb Company
        • Overview
        • Renewed Strategy - Focus on Prescription Drugs
      • Taro Pharmaceuticals Industries Ltd.
        • Overview.
        • R&D
        • OTC Pediatric Medication Product Line
        • New Product Introduction
        • Children's ElixSure IB NonSpil Ibuprofen Oral Suspension Syrup
        • Taro Children's Allergy Relief Fruit Flavored Syrup
        • Taro will Manufacture and Supply Elixsure Products to Alterna
      • Schering-Plough Corporation
        • Overview
        • OTC Pediatric Medication Product Line
        • FDA Approves Children’s Claritin

    APPENDIX: COMPANY DIRECTORY LIST OF EXHIBITS CHAPTER I: EXECUTIVE SUMMARY

    • Table 1-1: Retail Sales of U.S. OTC Pediatric Medication Categories, 2000-2005
    • Table 1-2: Retail Sales Projections of U.S. OTC Pediatric Medications 2005-2010

     

  • CHAPTER II: THE MARKET
    • Table 2-1: Common OTC Pediatric Cough, Cold, Allergy and Sinus Medications
    • Table 2-2: Selected Combination Products
    • Figure 2-1: Process for the study of On-Patent Drugs
    • Figure 2-2: FDA On-Patent Drug Exclusivity Process
    • Figure 2-3: Process for the Study of Off-Patent Drugs
    • Figure 2-4: FDA/NIH Off-Patent Drug Process
    • Table 2-3: Pediatric Exclusivity Labeling Changes as of November 23, 2005
    • Figure 2-5: Retail Sales of U.S. OTC Pediatric Medications, 2000-2005
    • Table 2-4: IRI-Tracked Retail Sales of U.S. OTC Pediatric Medication Categories, 2000-2005
    • Table 2-5: U.S. OTC Pediatric Medication Category Shares 2000-2005
    • Table 2-6: IRI-Tracked Retail Sales of Other U.S. OTC Pediatric Medication Categories, 2000-2005
    • Figure 2-6: U.S. Physician Visits by Specialty, 2002, (%)
    • Table 2-7: U.S. Physician Visit Rates by Select Physician Practice Characteristics, 2002
    • Figure 2-7: U.S. Population Not Visiting Physicians1 by Select Age Groups, 1997-2003 (%)
    • Figure 2-8: U.S. Population making One to Three Physician1 Visits Annually, by Select Age Groups, 1997-2003 (%)
    • Figure 2-9: U.S. Population Making Four to Nine Physician1 Visits Annually, by Select Age Groups, 1997-2003 (%)
    • Figure 2-10: U.S. Population Making Ten or More Physician1 Visits Annually, by Select Age Groups, 1997-2003 (%)
    • Table 2-8: U.S. Drug Therapeutic Class Recorded During Physician Visits for Persons Less than 18 Years of Age 95-96 versus 02-03
    • Figure 2-1: U.S. Physician Visits by Age and Gender, 2002.
    • Figure 2-12: U.S. Physician Visits by Age and Select Ethnicities, 2002
    • Table 2-9: U.S. Pediatric Cough/Cold Medication Preference by Type, 2005
    • Table 2-10: U.S. Select OTC Pediatric Drug Approvals, 1992-2004
    • Figure 2-13: National Health Expenditure, 1993-2003 (in US$ per capita and as % of GDP)
    • Table 2-11: National Health Expenditure, 2000-2003 (in billion $)
    • Table 2-12: Projected U.S. Health Expenditure and Per Capita Income, 2004-2010
    • Table 2-13: Uninsured Population by Age Group, 2003
    • Table 2-14: Population Spending Out-of-Pocket on Prescription Healthcare 1996-2002
    • Table 2-15: Population Covered by Private Insurance1 for Healthcare 1996-2002
    • Table 2-16: Population Spending Out-of-Pocket on Healthcare, 1998-2002
    • Table 2-17: Population Aged Less than 6 Years Spending Out-of-Pocket on Healthcare, 1998-2002, (%)
    • Table 2-18: Population Aged 6 to 17 Years Spending Out-of-Pocket on Healthcare, 1998-2002, (%)
    • Table 2-19: U.S. Consumer Price Index (CPI) for Medical Care Components, 2000-2004
    • Table 2-20: U.S. Younger Population Projections by Age Group (Under 5, 5 to 9, 10 to 14) 2000-2030 (in millions)
    • Table 2-21: Birth Rate and Women Age Group 2002-2003
    • Table 2-22: U.S. Physically Active Younger Population, Grades 9-12, 1999-2003
    • Table 2-23: U.S. Prevalence of Child Obesity, Age 6-11 years *, 1988-1994, 1999-2002 (%)
    • Figure 2-14: U.S. Prevalence of Pertussis, 1994-2003
    • Table 2-24: U.S. Generic Drug versus Branded Drug Performance
    • Table 2-25: U.S. Top Five Generic Drug Marketers 2004, (in million $)
    • Figure 2-15: Retail Sales Projections of U.S. OTC Pediatric Medications 2005-2010
    • Table 2-26: Retail Sales Projections of U.S. OTC Pediatric Medication Categories (Analgesics; Cold, Sinus, Allergy; Cough Syrups/Drops; First Aid; Other) 2005-2010

    CHAPTER III: THE MARKETERS

    • Table 3-1: IRI-Tracked Retail Sales for Leading OTC Pediatric Cough/Cold/Allergy/Sinus Marketers 2000-2005
    • Table 3-2: IRI-Tracked Retail Sales for Leading OTC Pediatric Cold/Allergy/ Sinus Liquid Brands 2000-2005
    • Table 3-3: IRI-Tracked Retail Sales for Select OTC Pediatric Cold/Allergy/Sinus Tablet Brands 2000-2005
    • Table 3-4: IRI-Tracked Retail Sales for Select OTC Pediatric Cough Syrup Brands, 2000-2005
    • Table 3-5: IRI-Tracked Retail Sales for Select OTC Pediatric Cough Drops Brands, 2000-2005:
    • Table 3-6: Unit Sales for Select OTC Pediatric Cold/Allergy/Sinus Brands 2004-200596
    • Table 3-7: Average Price per Unit for Select OTC Pediatric Cold/Allergy/ Sinus Brands, 2004-2005
    • Table 3-8: IRI-Tracked Retail Sales for Select OTC Pediatric First Aid Product Marketers, 2000-2005
    • Table 3-9: IRI-Tracked Retail Sales for Select OTC Pediatric First Aid Brands, 2000-2005
    • Table 3-10: Unit Sales for Select OTC Pediatric First Aid Brands, 2004-2005
    • Table 3-11: Average Price per Units for Select OTC Pediatric First Aid Brands, 2004-2005
    • Table 3-12: IRI-Tracked Retail Sales for Select OTC Pediatric Internal Analgesic Product Marketer/Brands, 2000-2005
    • Table 3-13: Unit Sales for Select OTC Pediatric Internal Analgesic Product Brands, 2004-2005
    • Table 3-14: Average Price per Unit For Select OTC Pediatric Internal Analgesic Product Brands, 2004-2005
    • Table 3-15: IRI-Tracked Retail Sales for Select OTC Pediatric Chest Rub Products Marketer, 2000-2005
    • Table 3-16: IRI-Tracked Retail Sales for Select OTC Pediatric Chest Rubs Product Brands, 2000-2005
    • Table 3-17: Unit Sales for Select OTC Pediatric Chest Rubs Product Brands, 2004-2005
    • Table 3-18: Average Price per Unit for Select OTC Pediatric Chest Rub Product Brands, 2004-2005
    • Table 3-19: IRI-Tracked Retail Sales for Select Nasal Aspirator Marketers, 2000-2005
    • Table 3-20: IRI-Tracked Retail Sales for Select Nasal Aspirator Brands, 2000-2005
    • Table 3-21: IRI-Tracked Retail Sales for Select Nasal Spray/Drops/Inhaler Marketers, 2000-2005
    • Table 3-22: IRI-Tracked Retail Sales for Select Nasal Spray/Drops/Inhaler Brands, 2000-2005
    • Table 3-23: Unit Sales for Select OTC Pediatric Nasal Product Brands, 2004-2005
    • Table 3-24: Average Price per Unit for Select OTC Pediatric Nasal Product Brands, 2004-2005
    • Table 3-25: IRI-Tracked Retail Sales for Select OTC Pediatric Bedwetting Remedies Product Marketers, 2000-2005
    • Table 3-26: IRI-Tracked Retail Sales for Select OTC Pediatric Bedwetting Remedies Product Brands, 2000-2005
    • Table 3-27: Unit Sales for Select OTC Pediatric Bedwetting Remedies Product Brands, 2004-2005
    • Table 3-28: Average Price per Unit for Select OTC Pediatric Bedwetting Remedies Product Brands, 2004-2005

    CHAPTER IV: THE CONSUMER

    • Table 4-1: Adult Demographic Profile of Children’s Cough/Cold (Non- Prescription) Product Users, May 2004 - May 2005
    • Figure 4-1: Percentage of Children’s Cough/Cold (Non-Prescription) Product Users, by Type, May 2004 - May 2005
    • Table 4-2: Adult Demographic Profile of Children’s Cough/Cold (Non- Prescription) Product Users, by Type, May 2004 - May 2005
    • Table 4-3: Adult Demographic Profile of Children’s Cough/Cold (Non- Prescription) Product Users, by Sole and Primary Type, May 2004 - May 2005
    • Figure 4-2: Percentage of Children’s Cough/Cold (Non-Prescription) Product Users, by Brand, May 2004 - May 2005
    • Table 4-4: Adult Demographic Profile of Children’s Cough/Cold (Non- Prescription) Product Users, by Brands: Children’s Tylenol, Robitussin Pediatric and Dimetapp, May 2004 - May 2005
    • Table 4-5: Adult Demographic Profile of Children’s Cough/Cold (Non-Prescription) Product Users, by Brands: Children’s Benadryl, Pediacare and Children’s Vicks Nyquil, May 2004 - May 2005
    • Table 4-6: Adult Demographic Profile of Children’s Fever/Pain Relief (Non- Prescription) Product Users, May 2004 - May 2005
    • Figure 4-3: Percentage of Children’s Fever/Pain Relief (Non-Prescription) Product Users, by Type, May 2004 - May 2005
    • Table 4-7: Adult Demographic Profile of Children’s Fever/Pain Relief (Non- Prescription) Product Users, by Type, May 2004 - May 2005
    • Table 4-8: Adult Demographic Profile of Children’s Fever/Pain Relief (Non- Prescription) Product, Sole and Primary Brand Users, May 2004 - May 2005.
    • Figure 4-4: Percentage of Children’s Fever/Pain Relief (Non-Prescription) Product Users, by Brand, May 2004 - May 2005
    • Table 4-9: Adult Demographic Profile of Children’s Cough/Cold (Non-Prescription) Product Users, by Brands: Children's Tylenol, Children's Motrin and Children's Advil, May 2004 - May 2005
    • Figure 4-5: Percentage of Children’s Cough/Cold (Non-Prescription) Product Users, by Frequency of Use, May 2004 - May 2005
    • Table 4-10: Adult Demographic Profile of Children’s Cough/Cold (Non-Prescription) Product Users, by Frequency of Use, May 2004 - May 2005
    • Figure 4-6: Percentage of First Aid Ointment/Antiseptic (Non-Prescription) Users, by Brand, May 2004 - May 2005
    • Table 4-11: Adult Demographic Profile of First Aid Ointment/Antiseptic (Non-Prescription) Users, by Brands: Band-Aid, Neosporin and Curad, May 2004 - May 2005
    • Table 4-12: Adult Demographic Profile of First Aid Antibiotic/Bandage (Non-Prescription) Store Brand Users, May 2004 - May 2005
    • Figure 4-7: Percentage of Anti-Itch (Non-Prescription) Product Users, by Brand, May 2004 - May 2005
    • Table 4-13: Adult Demographic Profile of Anti-Itch (Non-Prescription) Product Users, by Brands: Cortizone, Cortaid, Caladryl, Lanacane and Aveeno, May 2004 - May 2005.
    • Table 4-14: Adult Demographic Profile of Adhesive Bandage Users, May 2004 - May 2005
    • Figure 4-8: Percentage of Adhesive Bandage Users, by Brands, May 2004 - May 2005
    • Table 4-15: Demographic Profile of Adhesive Bandage Users (Kids aged 6-11), by Brands: Band-Aid, Curad Kid Size Happy Strips, and Disney Characters, May 2004 - May 2005
    • Table 4-16: Demographic Profile of Adhesive Bandage Users (Kids aged 6-11), by Brands: Looney Toons, Pokemon, Sesame Street and Store Brand, May 2004 - May 2005
    • Figure 4-9: Percentage of Adhesive Bandage Users, by Frequency of Use, May 2004 - May 2005
    • Table 4-17: Kids Demographic Profile of Adhesive Bandage Users, by Frequency of Use, May 2004 - May 2005

    CHAPTER V: MARKETING DYNAMICS

    • Table 5-1: U.S. Select OTC Pediatric Medication Marketers by Ad Spend, 2005
    • Table 5-2: Top Ten U.S. OTC Pediatric Medication Brands by Ad Spend, 2005
    • Table 5-3: U.S. Select Pediatric Medication Introductions Promoted with FSIs, 2004-2005.
    • Figure 5-1: U.S. First Aid Accessory Sales through Drug Stores, 2003-2004 (in million $)
    • Figure 5-2: U.S. First Aid Accessory Sales Through Drug Stores, 2003-2004 (in million units)
    • Table 5-4: Top U.S. First Aid Accessory Brands in Drug Stores, Sales and Share, 2004
    • Figure 5-3: U.S. Cold/Allergy/Sinus Liquid/Powder Sales through Drug Stores, 2003-2004
    • Figure 5-4: U.S. Cold/Allergy/Sinus Liquid/Powder Sales through Drug Stores, 2003-2004 (in million units)
    • Table 5-5: Top U.S. Cold/Allergy/Sinus Liquid/Powder Brands in Drug Stores, Sales and Share, 2004
    • Figure 5-5: U.S. Cough Syrup Sales through Drug Stores, 2003-2004
    • Figure 5-6: U.S. Cough Syrup Sales through Drug Stores, 2003-2004 (in million units)
    • Table 5-6: Top U.S. Cough Syrup Brands in Drug Stores, Sales and Share, 2004
    • Table 5-7: U.S. Pediatric Medication Categories by Number of SKUs Launched, 2004-2005:
    • Table 5-8: Top Ten U.S. Pediatric Medication Marketers by Number of SKUs Launched, 2004-2005
    • Table 5-9: Top Ten U.S. Pediatric Medication Brands by Number of SKUs Launched, 2004-2005
    • Table 5-10: U.S. Top Ten Pediatric Medication Package Tags by Number of Brands, 2004-2005
    • Table 5-11: U.S. Pediatric Cough and Cold Medication Introductions Tagged ‘Quick’, 2004-2005
    • Table 5-12: U.S. Pediatric First Aid Product Introductions Tagged ‘Quick’, 2004-2005
    • Table 5-13: U.S. Pediatric Analgesic Introductions Tagged ‘Quick’, 2004-2005
    • Table 5-14: U.S. Pediatric Medication Introductions Tagged ‘Instant’, 2004-2005
    • Table 5-15: U.S. Pediatric Cough and Cold Medication Introductions Tagged ‘Natural’*, 2004-2005
    • Table 5-16: U.S. Pediatric First Aid Product Introductions Tagged ‘Natural’*, 2004-2005
    • Table 5-17: U.S. Pediatric Analgesic Introductions Tagged ‘Natural’*, 2004-2005
    • Table 5-18: U.S. Pediatric Medication Introductions Tagged ‘No Allergy’, 2004-2005
    • Table 5-19: U.S. Pediatric Medication Introductions Tagged ‘No Sugar’, 2004-2005
    • Table 5-20: Top U.S. Pediatric Medication Introductions by Flavor/ Fragrance, 2004-2005
    • Table 5-21: U.S. Grape-Flavored Pediatric Cough and Cold Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-22: U.S. Grape-Flavored Pediatric Analgesic Introductions, Brand and Marketer, 2004-2005
    • Table 5-23: U.S. Cherry-Flavored Pediatric Medication Introductions, 2004-2005.184
    • Table 5-24: U.S. Orange-Flavored Pediatric Cough and Cold Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-25: U.S. Blended Pediatric Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-26: U.S. Bubblegum-Flavored Pediatric Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-27: U.S. Fruit-Flavored Pediatric Cough and Cold Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-28: U.S. Eucalyptus-Flavored Pediatric Cough and Cold Medication Introductions, Brand and Marketer, 2004-2005
    • Table 5-29: U.S. Pediatric Medication Introductions by Innovation, 2004-2005
    • Table 5-30: U.S. Pediatric Cough and Cold Medication Description, 2004-2005
    • Table 5-31: U.S. Pediatric First Aid Product Description, 2004-2005
    • Table 5-32: U.S. Pediatric Analgesic Product Description, 2004-2005.

    CHAPTER VI: COMPANY PROFILES

    • Table 6-1: P&G’s OTC Pediatric Brand Portfolio
    • Table 6-2: Johnson & Johnson OTC Pediatric Brand Portfolio
    • Table 6-3: Novartis OTC Pediatric Brand Portfolio.
    • Table 6-4: Pfizer Inc.’s OTC Pediatric Brand Portfolio
    • Table 6-5: Wyeth’s OTC Pediatric Brand Portfolio
    • Table 6-6: Prestige Brands OTC Pediatric Brand Portfolio
    • Table 6-7: Mentholatum’s OTC Pediatric Brand Portfolio
    • Table 6-8: 3M Company’s OTC Pediatric Brand Portfolio
    • Table 6-9: Curad’s OTC Pediatric Brand Portfolio
    • Table 6-10: Bristol-Myers Squibb OTC Pediatric Brand Portfolio
    • Table 6-11: Taro Pharmaceuticals OTC Pediatric Brand Portfolio
    • Table 6-12: Schering-Plough Corporation OTC Pediatric Brand Portfolio.

     

  • Other users found this report page using the following search terms: cough cold allergy sinus pain market motrin company pediatric curad cold sales pfizer com clear

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.